Fig. 8From: Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancerA Association of risk score with ESTIMATE, immune, and stromal scores and tumor purity. B Differences in ESTIMATE, immune, and stromal scores and tumor purity ratings between the two risk groups. C TIDE algorithm used to predict the probability of response to immune checkpoint inhibitor immunotherapy, categorizing patients into the two risk groupsBack to article page